The Role of Blood Culture Tests in Diagnosing Bacteremia Disease

August 21, 2024

The enduring legacy of Julius Richard Petri and his mentor Robert Koch, the founders of microbiology, is a testament to their unparalleled contributions. Their discovery of the methods of routine cultivation of bacteria and fungi, which have remained unchanged for over a century, continues to shape the field of microbiology and commands the respect and admiration of all those in the healthcare profession.

The Petri dish, a symbol of their legacy, is the most recognized and commonly used laboratory equipment. It is a constant reminder of their pioneering work and a source of inspiration for all those in the field. The historical significance of blood culture tests, a direct result of their work, is a connection to this legacy that all healthcare professionals share. It instills a sense of pride and responsibility in their work, reminding them of their critical role in patient care and the enduring impact of Petri and Koch’s work.

Medical diagnosis defines a patient’s clinical condition by classifying it into separate categories, allowing medical decisions. Aside from a detailed history and physical examination, no other diagnostic test offers more potentially life-saving information than blood cultures in patients with suspected bacteremia or fungemia. The timely and accurate interpretation of blood culture results can be a matter of life and death for the patient.

This article underscores the life-saving potential of blood culture tests in diagnosing bacteremia disease. It reminds healthcare professionals of their critical role in making decisions that can be lifesaving for their patients, underscoring the potential impact of their decisions and fostering a sense of responsibility and dedication in their work.

Importance of Blood Culture Tests in Diagnosing Bacteremia

When a physician sees a patient with a suspected infection, empiric treatment may be standard. Physicians may initiate antibiotics based solely on assumption or experience without complete information.

The likelihood of infection and the need for specific antibiotics based on practical experience may seem straightforward in many clinical scenarios, such as an erythematous wound draining fluid. However, in cases of upper respiratory infections or sore throats, the medical diagnosis may be elusive, and antibiotics may not be necessary because the pathogen may be a virus.

Patients with severe infections due to bacteremia may require more directed therapy using blood cultures, which are critical to clinical management. The biological mechanism of pathogenesis and the therapeutic mechanism of action are too complex to be decided based on empirical evidence. While proper sepsis protocol must be adhered to, and timely dosing of antibiotics can be lifesaving, broad-spectrum or “shotgun” antibiotic therapy may be ineffective and harmful because of potential antibiotic resistance.

Blood cultures fill in the information gaps, identifying the pathogen and guiding physicians to utilize narrow-spectrum antibiotics that specifically target the microorganism known to be causing the disease. This targeted therapy, a concept borrowed from cancer treatment, empowers healthcare professionals to combat bacteremia effectively by using drugs to target specific pathogens.

Microbiologic cultures are a cornerstone of medical diagnosis, treatment, and management. Identifying and characterizing pathogens allows physicians to focus on choosing the most appropriate medications and treatments, monitoring patient progress, and preventing the spread of infectious diseases. Blood cultures play a crucial role in identifying the offending microorganism, thereby avoiding the need for continued empiric treatment in patients who face potential sepsis, septic shock, and even death. This underscores healthcare professionals’ proactive and responsible role in managing infectious diseases.

Blood cultures are the gold standard in bacteremia diagnosis.

Blood cultures, the gold standard for detecting pathogens in a person’s blood, involves taking a sample of the patient’s blood and incubating it in a sterile environment to encourage the growth of any present bacteria or fungi. This process typically takes 24 to 48 hours, during which the sample is observed for signs of bacterial or fungal growth. The sample is first collected using a sterile needle and syringe and then transferred to a culture bottle containing a nutrient-rich medium, or directly from the vein into the culture bottle via an adapter. This bottle is then placed in an incubator set at body temperature, providing an ideal environment for the growth of any bacteria or fungi in the blood.

Bacteremia, the presence of bacteria in the bloodstream, can result from various activities, from everyday toothbrushing to severe infections. Fortunately, even serious local infections such as a urinary tract infection or a skin abscess do not always progress to a serious body-wide immune response known as sepsis, septicemia, and septic shock.

Most bacteria in the bloodstream remain clinically insignificant. However, those that escape the host immune response can pose a serious threat if left untreated. In such cases, blood culture tests are not just crucial; they are lifesaving in diagnosing and managing patients who may suffer life-threatening infections. This underscores the urgency of healthcare professionals’ actions in such situations and instills a sense of urgency and importance in their role.

Blood cultures guide targeted antibiotic therapy.

Blood cultures allow for identifying the specific pathogen causing bacteremia and sepsis, if present. They also guide the selection of appropriate antibiotic treatment based on susceptibility testing. A bloodstream infection may differ from sepsis since sepsis patients suffer from severe inflammatory or immune responses to the pathogens.

Sepsis may be caused by various pathogens, including bacteria, viruses, and fungi, from many locations, such as the lungs, brain, urinary tract, skin, and abdominal organs. Sepsis requires immediate treatment with intravenous fluids, antibiotics, and often intensive care. Sepsis has a high mortality rate, especially in vulnerable populations. Risk factors include the very old or young and those patients with weakened immune systems from cancer, diabetes, major trauma, burns, or other serious conditions.

Early diagnosis and targeted antibiotic therapy improve patient outcomes using blood cultures, particularly in patients with sepsis. Blood cultures aid in the initial diagnosis and play a crucial role in managing patients, empowering healthcare professionals to monitor the benefits of the prescribed antibiotics and make informed decisions.

Situations Where Blood Culture Testing is Particularly Important

Any physician who has treated patients with suspected sepsis will confirm the urgency of obtaining blood cultures. Blood cultures must be obtained as part of the workup and evaluation, as they can provide crucial information that can significantly impact patient outcomes. In suspected sepsis the SEP 1 Bundle must be adhered to which requires blood cultures.

Deciding whether a patient has clinically significant bacteremia may be difficult. Fever may be an ominous sign, but exceptions exist, particularly in the elderly and infants. Sepsis may also be caused by viral infections, such as COVID-19 or influenza, fungal infections, or major trauma. When sepsis occurs, multiple organs may fail, including the lungs, kidneys, and liver.

Diagnosing Sepsis:

For most clinical situations, patients with a fever, chills, rapid respiration, tachycardia, mental status changes or confusion, and edema are particularly problematic and may portend impending sepsis. Other signs of sepsis may include:

Serious electrolyte disorders, such as metabolic acidosis, rapid breathing, and respiratory acidosis.
Hypotension due to decreased vascular resistance
High cardiac output heart failure
Disorders of blood-clotting, bruising, bleeding, and organ failure
Low body temperature may be present in the elderly or immunocompromised (e.g., cancer, transplant recipients, HIV/AIDS)

Endocarditis, endovascular infections, and indwelling medical devices

There are other clinical situations where blood cultures are critically important. Every medical intern is taught early to look for infection or sepsis in patients with any type of indwelling catheter or device and unexplained clinical history.

First are patients with suspected endocarditis, a life-threatening inflammation of the inner lining of the heart chambers and valves, or other endovascular infections. These patients commonly have persistent bacteremia. Multiple blood culture sets are needed.

The clinical history in patients with endocarditis may be highly variable, vague, or only constitutional in nature. Although many develop fever and chills, many patients experience anorexia, malaise, headache, myalgia, shortness of breath, cough, or joint pains. Some will only exhibit cardiac signs of valvular insufficiency or congestive heart failure.

Bacteremia in endocarditis delivers the organisms to the heart’s surface, the organisms’ adherence, and the eventual invasion of the organisms into the valvular leaflets. A common occurrence is for a thrombus to form from sterile fibrin-platelet vegetation. Common challenges physicians encounter are fastidious organisms and inadequate blood volume taken during blood cultures.

Less common endovascular infections include septic thrombophlebitis and mycotic aneurysms. Septic thrombophlebitis includes the signs and symptoms of endocarditis with the addition of erythema and tenderness near the involved blood vessel. Mycotic aneurysms vary with location. Aortic mycotic aneurysms involve back and abdominal pain. If the mycotic aneurysm is a complication of endocarditis, the most common presentation is a stroke or subarachnoid hemorrhage.

Indwelling medical devices (e.g., central lines, prosthetic valves) may also place patients at higher risk of device-related bloodstream infections. It is often necessary to culture the device via the roll-plate semiquantitative method, but that approach requires catheter removal. In addition, multiple blood cultures should be drawn.

Factors Affecting the Sensitivity of Blood Cultures for Detecting Bacteremia

In medicine, sensitivity describes the accuracy of the blood culture report on the presence or absence of bacteremia. Sensitivity is also known as the true positive rate, which is the probability of a positive blood culture in a patient with bacteremia.

Sensitivity is also known as the detection rate. Theoretically, if blood cultures with 100% sensitivity were used, they would identify all patients with bacteremia.

The sensitivity of blood cultures is most related to the sample volume. Inadequate blood volume is a common reason for false-negative blood cultures. In adult blood cultures, sensitivity is increased if larger volumes, e.g., 10 mL per bottle, are obtained. Typically, two sets of two bottles are inoculated: one aerobic bottle and one anaerobic bottle.

Sensitivity is also related to the number of blood culture sets and the timing of blood culture collection relative to fever spikes. At least 2-3 blood culture sets from different venipuncture sites increases blood culture yield.

There is an unofficial rule in medical residency that obtaining a single blood culture set is no better than obtaining none. Single blood cultures do not yield an adequate volume to diagnose bacteremia or reliably identify a possible contaminated blood culture.

The timing of blood culture collection is important as it is best to draw blood cultures before antibiotic administration so the antibiotics do not interfere with collection and identification.

Interpreting Blood Culture Results and Guiding Treatment

A positive blood culture requires urgent treatment, but choosing the correct antibiotic involves proper pathogen identification and antibiotic susceptibility testing. If the microorganism resists a particular antibiotic, alternative antibiotic therapy should be considered. This subsequent tailoring of antibiotic therapy, post blood culture results will avoid inefficient treatment and resistant strains, limit host toxicity, and avoid negative impacts on beneficial bacteria.

Repeat blood cultures provide a mechanism for monitoring the successful clearance of bacteremia. Persistent positive blood cultures typically follow poor patient response to antibiotic therapy and may indicate treatment failure or complications. Many physicians utilize follow-up blood cultures to guide the duration of antibiotic therapy, particularly for certain infections such as endocarditis.

Contamination may cause false-positive blood cultures. The most common cause is skin contaminants such as coagulase-negative staphylococci, Corynebacterium spp, Bacillus spp, and Cutibacterium spp. Proper skin antisepsis, hand hygiene, and blood culture bottle antisepsis and removal of the first aliquot of blood are essential in avoiding contamination.

Limitations of Blood Cultures in Certain Situations

Unlike sensitivity, a blood test’s specificity is the probability of a negative test result when the patient does not have bacteremia. In other words, specificity measures the blood culture’s ability to correctly reject healthy patients without bacteremia.

Blood cultures may be negative despite the test’s high specificity and sensitivity. Negative blood cultures can result from fastidious or slow-growing organisms that may not be readily cultured, or they can occur if there has been prior antibiotic therapy.

Certain infections may fail to produce detectable bacteremia consistently. These infections include cellulitis and abscesses since they have localized or regional spread but are not systemic. Some intracellular pathogens, such as Rickettsia and Ehrlichia, may evade detection by standard blood culture techniques.

New technologies are changing the landscape of these limitations. Molecular tests (e.g., PCR) can detect bacterial DNA in blood. Serologic tests for antibodies against specific pathogens. These methods highlight the importance of innovation and implementation in patient care.

Conclusion

Blood cultures play an important role in diagnosing bacteremia disease. Instead of relying on empirical evidence or clinical experience, they provide essential information in particularly challenging clinical situations and provide treatment guidance when no other help may be available for critically ill patients.

Sources: